[F13(1)After receiving the report of the appropriate committee the licensing authority shall—U.K.
(a)decide whether to continue with the proposal to revoke, vary or suspend the product licence; and
(b)take the report into account when making their decision.
(2)The licensing authority shall then notify the holder of the licence of—
(a)the decision made pursuant to sub-paragraph (1) of this paragraph; and
(b)the advice given to them by the appropriate committee and the reasons for that advice.]
Textual Amendments
F1Sch. 2 substituted (30.10.2005) by Medicines (Advisory Bodies) Regulations 2005 (S.I. 2005/1094), reg. 1(1), Sch. 1 para. 15